Abbey B Berenson1, Mahbubur Rahman. 1. Department of Obstetrics and Gynecology and Center for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch, Galveston, TX 77555, USA. abberens@utmb.edu
Abstract
BACKGROUND: The study was conducted to estimate the effect of depot medroxyprogesterone acetate (DMPA) and oral contraceptives (OC) containing 20 mcg ethinyl estradiol on serum B12 and whether observed changes impact bone mineral density (BMD). STUDY DESIGN: Serum B12 and BMD at the lumbar spine and femoral neck were measured on 703 women using OC, DMPA or nonhormonal (NH) birth control at baseline and every 6 months thereafter for 3 years. RESULTS: OC and DMPA users experienced greater decreases in B12 than NH users (p<.001). A sharp decrease in B12 was observed during the first 6 months of hormonal contraceptive use (OC: 97 pg/mL and DMPA: 64 pg/mL) in contrast to 14 pg/mL among NH users (20%, 13% and 3% of their baseline values, respectively). Over the following 30 months, B12 levels of OC users remained almost flat, while DMPA users had a further 22-unit decrease. Very few women demonstrated B12 deficiency. Moreover, B12 levels were not associated with BMD. CONCLUSION: Hormonal contraception causes B12 levels to decrease, but this does not appear to be clinically significant or affect BMD.
BACKGROUND: The study was conducted to estimate the effect of depot medroxyprogesterone acetate (DMPA) and oral contraceptives (OC) containing 20 mcg ethinyl estradiol on serum B12 and whether observed changes impact bone mineral density (BMD). STUDY DESIGN: Serum B12 and BMD at the lumbar spine and femoral neck were measured on 703 women using OC, DMPA or nonhormonal (NH) birth control at baseline and every 6 months thereafter for 3 years. RESULTS: OC and DMPA users experienced greater decreases in B12 than NH users (p<.001). A sharp decrease in B12 was observed during the first 6 months of hormonal contraceptive use (OC: 97 pg/mL and DMPA: 64 pg/mL) in contrast to 14 pg/mL among NH users (20%, 13% and 3% of their baseline values, respectively). Over the following 30 months, B12 levels of OC users remained almost flat, while DMPA users had a further 22-unit decrease. Very few women demonstrated B12 deficiency. Moreover, B12 levels were not associated with BMD. CONCLUSION: Hormonal contraception causes B12 levels to decrease, but this does not appear to be clinically significant or affect BMD.
Authors: Marc W Sütterlin; Stefanie S Bussen; Lorenz Rieger; Johannes Dietl; Thomas Steck Journal: Eur J Obstet Gynecol Reprod Biol Date: 2003-03-26 Impact factor: 2.435
Authors: Thomas Gregor Issac; Soundararajan Soundarya; Rita Christopher; Sadanandavalli Retnaswami Chandra Journal: Indian J Psychol Med Date: 2015 Jan-Mar